The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
"seriously I think Anne's leaving in a chauffeur driven limo with her head held high".
Hope so, I'd hate to see her peddling away on a pushbike after slipping out of the back door on New Year's eve as we all still try and convince ourselves that no news is good news.
November in a weeks time , down to a five week window .
It will happen before December,
I hope the penny is finay dropping with everyone just how undervalued we are, still way below the 2p placing and cashed up to the gills!
Morning ladies a gentleman. How are we all this morning. Quiet as a church mouse here these days as we await " the coming".
ATB
Morning Chab,
News-packed Q4 now starting to feel more like it's going to be a news-packed P12.
Does anyone know if we still have a PR company or a broker?
Bit more volume and we will be on the road to recovery...
Looks like the mm's needed to sort out their paperwork today seeing today's trades.
Fingers crossed our PR will actually do something soon.
Quite pleased we're still hanging around a bit higher after the pump, still waaaay undervalued though, if people are holding back they could be too late
Aye, its clinging on to the gains which is good to see. Just the usual traders selling at a loss today.
I'm ever hopeful of something NXP004 related being announced in the near term, no foundation other than gut feeling as the research commenced back in May, so they've had a good chunk of time at it.
The news might not have too much info in it as they'll need to protect their patent filing, but the only thing we need to know is that its successful as that unlocks its role as a replacement for a blockbuster.
It's nice to see the price rise holding for a change but I had hoped that there would be more interest by now.
I would welcome any news that shows a change of fortune for this company and finally removes the awful feeling that things are always worse than the BoD are letting on. We have suffered enough uncertainty about what the future holds. It feels like no progress can be made while a question mark hangs over filling the CEO role. It's time we had some direction on that.
I still have nagging doubts that someone out there really wants to see this go under so that they can snap up the IP and take it private without having to pay a fair price. I hope I'm wrong.
Re last paragraph FX I worry the same which is why I can't help getting wound up when seeing the SP so low with non existent PR and a broker that says fair value starts below the SP at the time, just ridiculous
Agreed Filter.
I find it strange how the Oxilio deal has done little to change the situation either. We are still well below the minimum broker valuation without a deal. There seems to be alot of newsworthy excitement about OXL001 which is wonderful for Oxilio &TRX yet we seem to have been forgotten. I suppose that's down to the fact that the financial details remain a closely guarded secret. How can anyone judge that a fair deal has been struck while that is the case?
I was hoping that excitement about imminent news on NXP002 & NXP004 results would be increasing the momentum by now. An influx of new PI's might help to drive the price back to a level where it is out of the reach of potential vultures. The board seem unconcerned that the company might be exposed in that way. Perhaps we worry unnecessarily.
It doesn’t help when the company employs a broker and PR and yet refuses to tell them any details when they sign a global oncology licensing deal.
I guess we just need to do yet more waiting, communication has been poor, Q&A was a poor read. I've been most impressed with AR's interview and his letter recently.
Having said all this if the SP can recover back to 3p before news I'd be extremely happy
Exactly Soup, a global deal and hardly a whisper
Data driven filter….. just not that data
Though the Q&A was fine, it was more that most of the questions were poor, no company was ever going to talk about previous management decisions so totally pointless that people asked.
There are a few key items in there to hold them to.
AR’s letter should be take with a pinch of salt as it’s designed to appease frustration rather than report. Again that and his interview given some clues as to what was happening behind the scenes.
It’s just a waiting game and a binary bet on two results now. They gave up trying to build a business, so it’s all about whether they can make the product work.
Hit the nail on the head about gave up building a business which is why the end game has to be near, I can't see NFX being a thing by this time next year
It will be interesting to see how history judges the decision not to try and build something around NXP001, given it is the most advanced product.
If the global oncology market turns out to be more lucrative than the actual CINV market and the terms of the deal mean that Oxillo reap hundreds of millions in revenue while paying just a paltry £2m royalties (if we're still around) then I think that decision will have been a very bad one.
If NXP002 & NXP004 do disappoint then the only circumstance in which the deal could be regarded as good is if the upfront payment turned out to be significant enough to offer another lifeline via NXP001 in other markets. Failing that, the only winners might be Oxilio & their partners.
Needs some upwards movement
Pump the volume